Skip to main content
All lobbying clients

EMERGENT BIOSOLUTIONS INC.

Lobbying client · District of Columbia · filed 2025 to 2026

Biopharmaceutical Company

$5,225,000 Reported spend
32 Filings counted
4 Outside firms hired
6 Bills named

Spend is reported income plus in-house expenses across 32 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 5 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as EMERGENT BIOSOLUTIONS, EMERGENT BIOSOLUTIONS INC.

 Who filed for this client 5

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 6
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
    13 filings
  • H.R. 5252
    HOPE Act
    12 filings
  • H.R. 2483
    SUPPORT for Patients and Communities Reauthorization Act of 2025
    6 filings
  • H.R. 8800
    National Defense Authorization Act for Fiscal Year 2027
    6 filings
  • S. 4784
    National Defense Authorization Act for Fiscal Year 2027
    6 filings
  • H.R. 8870
    BUILD America 250 Act
    4 filings
 Reported by year 2 years
  • 2026 $2,145,000 12 filings
  • 2025 $3,080,000 20 filings
 Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 6
  • HOUSE OF REPRESENTATIVES 32
  • SENATE 32
  • Health & Human Services, Dept of (HHS) 11
  • White House Office 11
  • Office of Management & Budget (OMB) 7
  • Office of Natl Drug Control Policy (NDCP) 7
 Recent filings 32 total
Q3 report
CGCN GROUP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 19, 2026
View →
Q3 termination
THE NICKLES GROUP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $25,000 income · posted Oct 19, 2026
View →
Q3 report
CAPITOL COUNSEL LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 18, 2026
View →
Q3 report
EMERGENT BIOSOLUTIONS INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $450,000 expenses · posted Oct 13, 2026
View →
Q2 report
CGCN GROUP, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $70,000 income · posted Jul 19, 2026
View →
Q2 report
THE NICKLES GROUP, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 15, 2026
View →
Q2 report
EMERGENT BIOSOLUTIONS INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $510,000 expenses · posted Jul 14, 2026
View →
Q2 report
CAPITOL COUNSEL LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 8, 2026
View →
Q1 report
CGCN GROUP, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $70,000 income · posted Apr 20, 2026
View →
Q1 report
CAPITOL COUNSEL LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 15, 2026
View →
Q1 report
THE NICKLES GROUP, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 15, 2026
View →
Q1 report
EMERGENT BIOSOLUTIONS INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $730,000 expenses · posted Apr 14, 2026
View →
Q4 report
CGCN GROUP, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 20, 2026
View →
Q4 report
THE NICKLES GROUP, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $40,000 income · posted Jan 20, 2026
View →
Q4 report
CAPITOL COUNSEL LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 18, 2026
View →
Q4 termination
ALPINE GROUP PARTNERS, LLC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 17, 2026
View →
Q4 report
EMERGENT BIOSOLUTIONS INC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $430,000 expenses · posted Jan 16, 2026
View →
Q3 report
THE NICKLES GROUP, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2025
View →
Q3 report
CGCN GROUP, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2025
View →
Q3 report
ALPINE GROUP PARTNERS, LLC.
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 18, 2025
View →

Showing the 20 most recent of 32 filings. Search the explorer for "EMERGENT BIOSOLUTIONS INC.".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem